  To evaluate the efficacy and tolerability of baclofen vs. placebo for long-term treatment of alcohol use disorder. Systematic review and meta-analysis following methods of the Cochrane Collaboration Handbook ( PROSPERO registration: CRD42017073663). Primary outcome was the random-effects summary estimate of all standardized mean differences ( SMDs) , as calculated from the primary outcomes of each study. Fourteen double-blind RCTs ( 1522 patients) were included. Heterogeneity was substantial for most analyses ( I Our results question baclofen 's utility in the long-term treatment of alcohol use disorder at both normal and high doses. While the confidence intervals indicate that marginally harmful or moderately beneficial effects of baclofen remain a possibility , the most likely effect size is slightly above placebo effects.